Showing all 12 results
Entacavir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the potent antiviral API.
Active Ingredient Strength Primary Clinical Function Entecavir (as Monohydrate) USP/Ph.Eur. 0.5 mg The Global Nucleoside-Naive Standard: The definitive ultra-micro-dose utilized for the daily, lifelong suppression of HBV in patients who have never received prior antiviral therapy. Entecavir (as Monohydrate) USP/Ph.Eur. 1.0 mg The Refractory & Cirrhosis Standard: Double-strength therapeutic payload utilized specifically for patients with Lamivudine-resistant HBV viremia or those suffering from decompensated liver cirrhosis. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the microscopic 0.5mg payload is flawlessly distributed throughout the tablet matrix, preventing toxic “hot spots” or sub-therapeutic failures) *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic hepatology dispensing regimens).
Favipiravir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pyrazinecarboxamide derivative.
Active Ingredient Strength Primary Clinical Function Favipiravir USP/Ph.Eur. 200 mg The Global Outbreak Standard: Base therapeutic unit utilized for standard, highly flexible titration during acute viral hemorrhagic fevers or novel influenza outbreaks. Favipiravir USP/Ph.Eur. 400 mg / 800 mg The Pill-Burden Reduction Macrodose: Massive therapeutic payload engineered specifically to solve the severe “Day 1 Loading Dose” compliance nightmare (allowing a patient to take two 800mg pills instead of eight 200mg pills). Excipients Microcrystalline Cellulose / Crospovidone / Povidone K-30 / Colloidal Silicon Dioxide / Sodium Stearyl Fumarate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Lubricant (Engineered specifically utilizing advanced high-shear wet granulation to compress massive, bulky API doses into smooth, easily swallowable tablets, finished with a heavy film-coat to lock out tropical humidity) *Pack Sizes: 10×10 Alu-Alu Blisters or Complete Therapy “Outbreak Kits” (e.g., 34-tablet or 40-tablet regimen boxes).
Ganciclovir Capsules
FreeGanciclovir capsules (commonly found in 250 mg and 500 mg strengths) contain the active antiviral drug ganciclovir, a synthetic guanine derivative used to treat and prevent cytomegalovirus (CMV) infections
Ganciclovir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient and protect healthcare handlers from cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Ganciclovir USP/Ph.Eur. 250 mg Renal Titration Standard: Base therapeutic unit utilized for strict, calculated dose reductions in transplant patients suffering from severe renal impairment (low creatinine clearance). Ganciclovir USP/Ph.Eur. 500 mg Global Maintenance Standard: High-efficacy adult maintenance dose utilized for daily, long-term suppression of CMV retinitis to prevent viral relapse. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically to lock the highly mutagenic and carcinogenic API safely inside the tablet, completely preventing caregiver and pharmacist exposure to toxic airborne dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 84 (Optimized specifically for strict, high-volume chronic infectious disease dispensing regimens).
Ledipasvir & Sofosbuvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dual-Active FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles with specialized desiccants to ensure the absolute chemical survival of the complex antiviral APIs.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg The NS5A Anchor: Potent inhibitor of viral assembly and secretion; highly effective against specific HCV genotypes. Sofosbuvir USP/Ph.Eur. 400 mg The NS5B Backbone: The globally recognized foundational DAA that forces viral RNA chain termination across multiple genotypes. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Binder / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically to solve the massive solubility differences between the highly soluble Sofosbuvir and the poorly soluble Ledipasvir, guaranteeing synchronized gastric release and peak systemic absorption) *Pack Sizes: Bottles of 28 (Optimized specifically for the strict 4-week dispensing intervals required for 8, 12, or 24-week curative regimens).
Ledipasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Solid-Dispersion Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical survival of the complex antiviral API.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg Global Hepatology Standard: The definitive daily dose required to maintain constant, paralyzing pressure on the NS5A viral protein across the entire 12-to-24 week curative cycle. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Solubility Enhancer / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion techniques with Copovidone to force the highly insoluble Ledipasvir to dissolve instantly in gastric fluid, guaranteeing maximum systemic bioavailability) *Pack Sizes: Bottles of 28 or 10×10 Blisters (Optimized specifically for strict 4-week dispensing intervals to match custom DAA combination regimens).
Oseltamivir Tablet
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Hard Gelatin Capsule, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the hygroscopic phosphate salt.
Active Ingredient Strength Primary Clinical Function Oseltamivir Phosphate USP/Ph.Eur. 75 mg (Equivalent to Oseltamivir free base) Global Standard: Target adult dose for rapid treatment and prophylaxis of Influenza A/B. Excipients Pregelatinized Starch / Croscarmellose Sodium / Povidone / Sodium Stearyl Fumarate Diluent / Superdisintegrant (Engineered for immediate gastric capsule rupture and rapid systemic absorption) *Pack Sizes: 1×10 Blisters (Optimized perfectly for the standard 5-day acute treatment regimen of two capsules daily).
Ribavirin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the stability of the active nucleoside analog and protect handlers from exposure.
Active Ingredient Strength Primary Clinical Function Ribavirin USP/Ph.Eur. 200 mg Global Clinical Standard: Base titration unit for precise, weight-based antiviral dosing. Ribavirin USP/Ph.Eur. 400 mg High-dose unit to drastically improve pill-burden compliance in heavy patients. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Magnesium Stearate Diluent / Superdisintegrant / Binder (Engineered for immediate gastric dissolution and rapid systemic absorption) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-dose, weight-based daily regimens requiring 4 to 6 tablets per day).
Sofosbuvir & Ledipasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles containing exactly 28 tablets to perfectly align with strict clinical dispensing cycles.
Active Ingredient Strength Primary Clinical Function Sofosbuvir INN/Ph.Eur. 400 mg NS5B RNA polymerase inhibition to terminate viral RNA chain synthesis. Ledipasvir INN/Ph.Eur. 90 mg NS5A protein inhibition to halt viral replication and physical virion assembly. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Binder / Diluent / Superdisintegrant (Engineered for strict synchronized gastric dissolution) Sofosbuvir & Velpatasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles containing exactly 28 tablets to perfectly align with strict 12-week clinical dispensing cycles.
Active Ingredient Strength Primary Clinical Function Sofosbuvir INN/Ph.Eur. 400 mg NS5B RNA polymerase inhibition to terminate viral RNA chain synthesis. Velpatasvir INN/Ph.Eur. 100 mg NS5A protein inhibition to halt viral replication and physical virion assembly. Excipients Copovidone / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate Binder / Diluent / Superdisintegrant (Engineered for strict synchronized gastric dissolution) Sofosbuvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or ultra-dense Alu-Alu blister strips to ensure the absolute chemical stability of the nucleotide analog.
Active Ingredient Strength Primary Clinical Function Sofosbuvir INN/Ph.Eur. 400 mg Global Standard: Base NS5B polymerase inhibition for daily combination HCV therapy. Excipients Mannitol / Microcrystalline Cellulose / Croscarmellose Sodium / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Superdisintegrant / Glidant (Engineered for immediate gastric dissolution and high bioavailability) Valganciclovir Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles for chronic dispensing regimens.
Active Ingredient Strength Primary Clinical Use Valganciclovir Hydrochloride USP/Ph.Eur. 450 mg (Equivalent to Valganciclovir free base) Standard Adult Dose for CMV retinitis induction/maintenance and transplant prophylaxis. Excipients Povidone / Crospovidone / Microcrystalline Cellulose / Stearic Acid Binder / Superdisintegrant / Diluent (Ensures rapid gastric dispersion and prodrug integrity)
